Kallikrein 9 antibody (N-Term)

Catalog No. ABIN390306

The Rabbit Polyclonal anti-Kallikrein 9 antibody (Clone RB6478) (ABIN390306) specifically detects Kallikrein 9 in WB. The antibody is reactive with Human and Mouse samples.

Quick Overview for Kallikrein 9 antibody (N-Term) (ABIN390306)

Target: Kallikrein 9 (KLK9)

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Kallikrein 9 antibody is un-conjugated

Application: Western Blotting (WB)

Clone: RB6478

Product Details anti-Kallikrein 9 Antibody

Binding Specificity: AA 1-30, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This Kallikrein 9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human Kallikrein 9.

Isotype: Ig Fraction

Application Details

Application Notes: WB: 1:1000. WB: 1:1000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Expiry Date: 6 months

Target Details for Kallikrein 9

Target: Kallikrein 9 (KLK9)

Background: Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK9 is a novel kallikrein with poptential application for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.

Molecular Weight: 27513

Gene ID: 284366

NCBI Accession: NP_036447

UniProt: Q9UKQ9

Pathways: Complement System